| Samsung Bioepis CH GmbH - Xbryk 120 mg/1.7 ml, Injektionslösung |
| 69874 | | 01 | | Xbryk 120 mg/1.7 ml | | Injektionslösung | | M05BX04 | | Denosumab | | 21.03.2025 | | |
|
| Composition |
| denosumabum 120 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, sorbitolum 74.8 mg, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Denosumabum | 120mg / 1.7ml |
| | BAG: Principe actif |
|---|
| Denosumabum |
| | | | Agents auxilliaires | Concentr. |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Polysorbatum 20 | | | Sorbitol | 74.8mg / 1.7ml |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 172.04 | 210.45 | A | LS | Non |
|
